New medical guideline features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic. Boxes of Ozempic and Wegovy are seen at a pharmacy in London, England, on March 8, 2024.

Doctors caring for young people with obesity should provide nutritionaland exercise advice, but should also consider offering weight-loss drugs and bariatric surgery to teenagers, according to the first new Canadian guideline on the treatment of pediatric obesity in nearly 20 years.

The clinical practice guideline, which provides advice to doctors on how to treat children with obesity, was published Monday in the Canadian Medical Association Journal. It features 10 recommendations, including one in favour of GLP-1 receptor agonists, the class of drugs that contains semaglutide, better known as the Type 2 diabetes medication Ozempic.


From The Globe and Mail via this RSS feed

  • jetA
    link
    fedilink
    English
    arrow-up
    3
    arrow-down
    1
    ·
    2 months ago

    The article is behind a paywall, but I assume they’re talking about this https://www.cmaj.ca/content/197/14/E372

    From table 1

    1.2 Nutrition interventions

    We suggest using nutritional interventions for managing obesity in children aged 18 years and younger.

    Rationale: For critically important outcomes, no data were available, but for our very important outcome (BMIz), compared with minimal interventions, nutrition interventions had a small beneficial effect. No serious AEs were reported in any nutrition intervention studies. When mild to moderate AEs were reported, they were trivial. This recommendation relates to nutrition interventions exclusively, not in conjunction with other interventions.

    This really should be the main focus of their guidance, not a sidenote… Sugar and carbs are making these kids sick